The release of excellent interim results in the HER-Vaxx Phase 2 trial will speed the recruitment of the rest of the patients required to complete it. As the IDMC now says that a total of only 34 patients is enough (down from 68), only another 7 are required. This shouldn't take long now. Expect final results in the second half of calendar 21.
In the meantime Imugene is evidently moving forward on other fronts. I think we can reasonably expect a positive announcement of some sort before the end of the year - eg first patient dosed with PD1-Vaxx, or complete enrolment for HER-Vaxx Phase 2.
The next announcement that IMO would be likely to put a motor under the share price would be FDA IND clearance for CF33/ Checkvacc. I'd guess we'll hear about that within the next 3-4 months.
But DYOR!
- Forums
- ASX - By Stock
- IMU
- Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform'
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform', page-242
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 286362 | 0.055 |
9 | 2036888 | 0.054 |
16 | 2736044 | 0.053 |
20 | 1943436 | 0.052 |
23 | 3206056 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 378902 | 2 |
0.058 | 1552127 | 7 |
0.059 | 837099 | 8 |
0.060 | 2176188 | 16 |
0.061 | 1163926 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online